SCORSETTI, Marta
 Distribuzione geografica
Continente #
NA - Nord America 18.627
AS - Asia 11.462
EU - Europa 3.600
SA - Sud America 2.348
AF - Africa 576
OC - Oceania 44
Continente sconosciuto - Info sul continente non disponibili 19
AN - Antartide 1
Totale 36.677
Nazione #
US - Stati Uniti d'America 18.266
SG - Singapore 7.272
BR - Brasile 1.926
CN - Cina 1.718
VN - Vietnam 1.178
FI - Finlandia 647
DE - Germania 608
IE - Irlanda 540
IT - Italia 431
NG - Nigeria 363
HK - Hong Kong 317
FR - Francia 309
GB - Regno Unito 238
CA - Canada 189
IN - India 188
NL - Olanda 186
SE - Svezia 157
AR - Argentina 151
RU - Federazione Russa 115
BD - Bangladesh 108
TR - Turchia 90
IQ - Iraq 85
MX - Messico 84
EC - Ecuador 68
ID - Indonesia 67
ZA - Sudafrica 60
CO - Colombia 55
PK - Pakistan 54
CL - Cile 52
IL - Israele 51
UA - Ucraina 50
PL - Polonia 48
ES - Italia 43
BE - Belgio 39
AU - Australia 38
SA - Arabia Saudita 36
JP - Giappone 35
VE - Venezuela 35
AT - Austria 32
MA - Marocco 30
UZ - Uzbekistan 30
CZ - Repubblica Ceca 25
JO - Giordania 25
KE - Kenya 24
DZ - Algeria 22
EG - Egitto 22
PY - Paraguay 21
NP - Nepal 20
KZ - Kazakistan 19
MY - Malesia 19
PE - Perù 19
LT - Lituania 18
OM - Oman 18
RO - Romania 18
AE - Emirati Arabi Uniti 17
AZ - Azerbaigian 17
PH - Filippine 17
TN - Tunisia 17
JM - Giamaica 16
UY - Uruguay 15
A2 - ???statistics.table.value.countryCode.A2??? 13
CH - Svizzera 11
CR - Costa Rica 11
GR - Grecia 11
HN - Honduras 11
NO - Norvegia 9
PA - Panama 9
AL - Albania 8
DO - Repubblica Dominicana 8
LB - Libano 8
BG - Bulgaria 7
IR - Iran 7
PS - Palestinian Territory 7
PT - Portogallo 7
SN - Senegal 7
CI - Costa d'Avorio 6
GE - Georgia 6
GT - Guatemala 6
HU - Ungheria 6
AM - Armenia 5
BA - Bosnia-Erzegovina 5
BH - Bahrain 5
BO - Bolivia 5
BY - Bielorussia 5
DK - Danimarca 5
ET - Etiopia 5
HR - Croazia 5
KG - Kirghizistan 5
KH - Cambogia 5
KR - Corea 5
KW - Kuwait 5
TT - Trinidad e Tobago 5
BB - Barbados 4
EU - Europa 4
GA - Gabon 4
NI - Nicaragua 4
NZ - Nuova Zelanda 4
SI - Slovenia 4
SV - El Salvador 4
SY - Repubblica araba siriana 4
Totale 36.613
Città #
Singapore 3.274
Wilmington 2.603
Chandler 2.172
Dallas 1.832
Ashburn 1.041
The Dalles 1.034
San Mateo 1.014
Shanghai 763
San Jose 743
Ann Arbor 720
Helsinki 644
Dublin 535
Leawood 456
Lawrence 438
Princeton 438
Boardman 404
Ho Chi Minh City 384
Beijing 368
Benin City 361
New York 333
Hanoi 296
Hong Kong 277
Fairfield 261
Woodbridge 252
Paris 240
Falkenstein 239
São Paulo 181
Santa Clara 170
Amsterdam 152
Los Angeles 150
Milan 126
London 109
Seattle 99
Toronto 89
Buffalo 87
Norwalk 72
Rio de Janeiro 63
Orem 59
Da Nang 56
San Diego 53
Belo Horizonte 49
Phoenix 47
Kocaeli 46
Haiphong 45
Council Bluffs 44
Brussels 37
Chennai 36
Baghdad 35
Mexico City 35
Warsaw 34
Porto Alegre 32
Curitiba 31
Montreal 30
Naples 30
Tokyo 30
Brasília 29
Dhaka 28
Hillsboro 27
Munich 27
Brooklyn 26
Frankfurt am Main 26
Tashkent 25
Charlotte 24
Guarulhos 24
Guayaquil 24
Johannesburg 24
Nuremberg 24
Amman 23
Hải Dương 23
Pune 23
Redwood City 23
Campinas 21
Fortaleza 21
Thái Bình 21
Des Moines 20
Nairobi 20
Salvador 20
San Francisco 20
Santiago 20
Biên Hòa 19
Chicago 19
Denver 19
Manchester 19
Monmouth Junction 19
Can Tho 18
Lahore 18
Quito 18
Redmond 18
Vienna 18
Boston 17
Columbus 17
Moscow 17
Ninh Bình 17
Santo André 17
Stockholm 16
Atlanta 15
Osasco 15
Recife 15
Brno 14
Erbil 14
Totale 24.071
Nome #
11C-Choline-Pet Guided Stereotactic Body Radiation Therapy for Lymph Node Metastases in Oligometastatic Prostate Cancer. 754
11C Choline PET Guided Salvage Radiotherapy with Volumetric Modulation Arc Therapy and Hypofractionation for Recurrent Prostate Cancer after HIFU Failure: Preliminary Results of Tolerability and Acute Toxicity 679
Aggressive and Multidisciplinary Local Approach to Iterative Recurrences of Colorectal Liver Metastases 141
Are three weeks hypofractionated radiation therapy (HFRT) comparable to six weeks for newly diagnosed glioblastoma patients? Results of a phase II study 134
"Early Clinical Assessment Of Feasibility And Safety In Flattering Filter Free (FFF) Based Stereotactic Body Radiotherapy (SBRT) Treatments" 133
Can advanced new radiation therapy technologies improve outcome of high grade glioma (HGG) patients? Analysis of 3D-conformal radiotherapy (3DCRT) versus volumetric-modulated arc therapy (VMAT) in patients treated with surgery, concomitant and adjuvant chemo-radiotherapy 130
Assessment of prognostic factors in patients with metastatic epidural spinal cord compression (MESCC) from solid tumor after surgery plus radiotherapy: a single institution experience 129
Carbon-11-methionine PET-CT as an imaging biomarker in brain gliomas eligible for surgery 127
A circulating miRNA signature to implement diagnostic imaging analysis in young early-stage breast cancer patients 127
Addition of temozolomide to radiotherapy for treatment of newly diagnosed anaplastic gliomas 123
Hypofractionation with simultaneous boost in breast cancer patients receiving adjuvant chemotherapy: A prospective evaluation of a case series and review of the literature 122
Administration of temozolomide during and after radiotherapy for newly diagnosed high-grade gliomas excluding glioblastoma multiforme 122
High incidence of hypocalcemia and serum creatinine increase in patients with bone metastases treated with zoledronic acid 119
"Reirradiation: hopes and concerns of the radiation oncologist" Reply 117
A broad scope knowledge based model for optimization of VMAT in esophageal cancer: validation and assessment of plan quality among different treatment centers. 114
Can HSRS on tumor bed replace WBRT in resected brain metastases? Results of a phase II study 113
A national multicenter study on 1072 DCIS patients treated with breast-conserving surgery and whole breast radiotherapy (COBCG-01 study) 113
A Radiomic Approach to Predict Nodal and Distant Relapse in Patients Treated with Stereotactic Body Radiation Therapy for Early Stage NSCLC 113
Accuracy evaluation of fusion of CT, MR, and SPECT images using commercially available software packages (SRS PLATO and IFS) 112
ChemoRadiotherapy for Oesophageal cancer followed by Surgery Study (CROSS): Single Center Experience 112
A Large, Multicenter, Retrospective Study on Efficacy and Safety Of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Ovarian Cancer (MITO RT1 Study): A Collaboration of MITO, AIRO GYN, and MaNGO Groups 111
Can SBRT improve the prognosis of unresectable pancreatic cancer? Clinical results on 106 patients 111
Role of Surgical Resection in Patients with Single Large Brain Metastases: Feasibility, Morbidity, and Local Control Evaluation. 110
A Bibliometric Analysis of the Oligometastatic State over the Last Two Decades: A Shifting Paradigm for Oncology? An AIRO Oligometastatic Study Group 109
A LARGE, MULTICENTER, RETROSPECTIVE STUDY ON EFFICACY AND SAFETY OF STEREOTACTIC BODY RADIOTHERAPY (SBRT) IN OLIGOMETASTATIC OVARIAN CANCER (MITO RT1 STUDY) 109
Outcome appraisal of patients with limited brain metastases (BMs) from non small cell lung cancer (NSCLC) treated with different local therapeutic strategies: a single institute evaluation. 108
A radiomic approach to predicting nodal relapse and disease-specific survival in patients treated with stereotactic body radiation therapy for early-stage non-small cell lung cancer. 108
Adjuvant chemotherapy and hypofractionated VMAT treatment with SIB for early stage breast cancer: A prospective evaluation of acute toxicity and cosmetic results 104
Prognostic value of molecular and imaging biomarkers in patients with supratentorial glioma 103
SALVAGE RADIOTHERAPY WITH VOLUMETRIC MODULATION ARC THERAPY AND HYPOFRACTIONATION FOR RECURRENT PROSTATE CANCER AFTER HIFU FAILURE 103
Survival outcome and prognostic factors after pulmonary metastasectomy in sarcoma patients 102
Adjuvant volumetric modulated arc therapy compared to 3D conformal radiation therapy for newly diagnosed soft tissue sarcoma of the extremities: outcome and toxicity evaluation 101
Checkpoint inhibitors as treatment for malignant gliomas: "A long way to the top" 101
Accuracy evaluation of the optical surface monitoring system on EDGE linear accelerator in a phantom study. 101
Hypofractionated radiation therapy (HFRT) versus conventional fractionated radiation therapy (CRT) for newly diagnosed glioblastoma patients. A propensity score matched analysis. 100
Can stereotactic body radiation therapy be a viable and efficient therapeutic option for unresectable locally advanced pancreatic adenocarcinoma? Results of a phase 2 study 100
Cranio-spinal irradiation with volumetric modulated arc therapy: A multi-institutional treatment experience 100
Adjuvant radiotherapy in endometrial cancer: Volumetric Modulated Intensity Arc Therapy vs 3DRT 99
A Multi-Institutional Analysis on the Use of Stereotactic Body Radiotherapy (SBRT) for the Treatment of Lymph Node Oligometastases in Prostate Cancer Patients 99
AI differentiates radionecrosis from true progression in brain metastasis upon stereotactic radiosurgery: analysis of 124 histologically assessed lesions 98
Diagnostic accuracy of C-11-choline PET/CT in comparison with CT and/or MRI in patients with hepatocellular carcinoma 98
Computed tomography based radiomic signature as predictive of survival and local control after stereotactic body radiation therapy in pancreatic carcinoma 97
Applying failure mode effects and criticality analysis in radiotherapy: Lessons learned and perspectives of enhancement 96
Stereotactic Ablative Radiotherapy (SABR) in inoperable oligometastatic disease from colorectal cancer: a safe and effective approach 96
Long-Term Follow-up Results of the DANTE Trial, a Randomized Study of Lung Cancer Screening with Spiral Computed Tomography 96
Intensity modulated proton therapy compared to volumetric modulated arc therapy in the irradiation of young female patients with hodgkin's lymphoma. Assessment of risk of toxicity and secondary cancer induction 94
Role of C-11-choline PET/CT in radiation therapy planning of patients with prostate cancer 91
Acute Toxicity and Quality of Life in a Post-Prostatectomy Ablative Radiation Therapy (POPART) Multicentric Trial 90
Hypofractionated stereotactic radiation therapy in skull base meningiomas 90
Developing an adolescent and young adult (AYA) cancer program in an Italian adult high-volume cancer center. 90
DCIS treated with breast conservative surgery and radiotherapy: a national multicentre experience 90
Early clinical experience with volumetric modulated arc therapy in head and neck cancer patients 88
Liver metastases from colorectal cancer: propensity score-based comparison of stereotactic body radiation therapy vs. microwave ablation 88
Phase II trial of stereotactic body radiation therapy for abdomino-pelvic lymph node oligometastases 88
Multimodality therapy approaches, local and systemic treatment, compared with chemotherapy alone in recurrent glioblastoma 88
Stereotactic body radiation therapy for lung metastases from soft tissue sarcoma. 87
Deep learning-based optimization of field geometry for total marrow irradiation delivered with volumetric modulated arc therapy 86
Adjuvant radiotherapy for malignant pleural mesothelioma: Challenges and pitfalls 86
Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation 86
Percutaneous Vertebral Augmentation in Metastatic Disease: State of the Art 86
The use of radiation therapy for oligoprogressive/oligopersistent oncogene driven non small cell lung cancer: state of the art 86
Oligometastatic Prostate Cancer Treated with Stereotactic Body Radiation Therapy: The Role of Three-Dimensional Tumour Volume in Patient Survival 85
Recurrence pattern of stereotactic body radiotherapy in oligometastatic prostate cancer: a multi-institutional analysis. 85
Can thoracic nodes oligometastases be safely treated with image guided hypofractionated radiation therapy? 85
Investigation on the role of integrated PET/MRI for target volume definition and radiotherapy planning in patients with high grade glioma 84
Could single-high-dose radiotherapy be considered the new frontier of stereotactic ablative radiation therapy? 84
Hypofractionation in current clinical practice: a flash forward to the near future of radiation oncology? 84
Final results of a phase II trial for stereotactic body radiation therapy for patients with inoperable liver metastases from colorectal cancer 84
SBRT in unresectable advanced pancreatic cancer: preliminary results of a mono-institutional experience. 84
Mesenchymal Tumor Management: Integrating Surgical and Non-Surgical Strategies in Different Clinical Scenarios 83
Organs at risk in lung SBRT 83
Bronchoscopically-guided conformal radiation therapy for radiographically occult lung carcinoma 83
The 70-year-old newly diagnosed glioblastoma patients are older than the 65-year-old? Outcome evaluation of the two categories in a matched case control study with propensity score balancing 83
Repeated HyperArc radiosurgery for recurrent intracranial metastases and dosimetric analysis of recurrence pattern to account for diffuse dose effect on microscopical disease 82
Stereotactic body radiotherapy (sbrt) in lung oligometastatic patients: role of local treatments. 82
Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study. 82
CRITICAL APPRAISAL OF VOLUMETRIC MODULATED ARC THERAPY IN STEREOTACTIC BODY RADIATION THERAPY FOR METASTASES TO ABDOMINAL LYMPH NODES 82
Liver Metastases-directed Therapy in the Management of Oligometastatic Breast Cancer 82
Intracranial Meningiomas: A Systematic Analysis of Prognostic Factors for Recurrence in a Large Single Institution Surgical Series 81
STEREOTACTIC BODY RADIATION THERAPY AS LOCAL TREATMENT FOR OLIGOMETASTASES FROM PROSTATE CANCER: EFFICACY AND IMPACT ON SYSTEMIC TREATMENT 81
A predictive model of polymetastatic disease from a multicenter large retrospectIve database on colorectal lung metastases treated with stereotactic ablative radiotherapy: The RED LaIT-SABR study 80
Comparison of low dose total marrow/total lymphoid irradiation (TMI/TLI) and TBI in haploidentical transplant platform: a retrospective analysis 80
VOLUMETRIC MODULATION ARC RADIOTHERAPY COMPARED WITH STATIC GANTRY INTENSITY-MODULATED RADIOTHERAPY FOR MALIGNANT PLEURAL MESOTHELIOMA TUMOR: A FEASIBILITY STUDY 80
Role of surgical resection in recurrent glioblastoma: prognostic factors and outcome evaluation in an observational study. 80
Assessing the role of Stereotactic Body Radiation Therapy in a large cohort of patients with lymph node oligometastases: Does it affect systemic treatment's intensification? 80
Discrepancies between UICC and AJCC TNM classifications for oral cavity tumors in the 8th editions and following versions 79
A multicenter LArge retrospectIve daTabase on the personalization of stereotactic ABlative radiotherapy use in lung metastases from colon-rectal cancer: The LaIT-SABR study 79
Plan robustness in field junction region from arcs with different patient orientation in total marrow irradiation with VMAT. 79
Critical Appraisal of the Risk of Secondary Cancer Induction From Breast Radiation Therapy With Volumetric Modulated Arc Therapy Relative to 3D Conformal Therapy. 79
High-grade gliomas (HGGs) and immunotherapeutic early-phase clinical trials (ieCTs): A single-center experience 79
Adjuvant chemotherapy and hypofractionated VMAT treatment with SIB for early stage breast cancer 79
Applying Lean-Six-Sigma Methodology in radiotherapy: Lessons learned by the breast daily repositioning case 79
Outcome Evaluation of Oligometastatic Patients Treated with Surgical Resection Followed by Hypofractionated Stereotactic Radiosurgery (HSRS) on the Tumor Bed, for Single, Large Brain Metastases. 79
Temozolomide combined with radiotherapy in the treatment of recurrent cranial meningioma previously treated with multiple surgical resections and two sessions of radiosurgery: a case report and literature review. 79
Preservation of Axillary Lymph Nodes Compared with Complete Dissection in T1-2 Breast Cancer Patients Presenting One or Two Metastatic Sentinel Lymph Nodes: The SINODAR-ONE Multicenter Randomized Clinical Trial 78
Hypofractionated Stereotactic Radiation Therapy in Recurrent High-Grade Glioma: A New Challenge. 78
SBRT for unresectable locally advanced pancreatic cancer: clinical outcomes on 100 patients 78
Stereotactic Body Radiation Therapy (SBRT) for adrenal metastases A Feasibility Study of Advanced Techniques with Modulated Photons and Protons 78
HIGH-GRADE GLIOMAS AND IMMUNOTHERAPEUTIC EARLY PHASE CLINICAL TRIALS: A SINGLE-CENTER EXPERIENCE 78
Long term follow up of Metastatic Epidural Spinal Cord Compression (MESCC) patients from breast cancer treated with surgery followed by radiotherapy. 78
Totale 10.766
Categoria #
all - tutte 248.172
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 248.172


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021493 0 0 0 0 0 0 0 0 0 0 0 493
2021/20222.197 98 21 31 545 13 10 87 367 195 236 513 81
2022/20236.230 950 184 550 711 552 514 9 520 1.176 533 461 70
2023/20243.204 206 383 736 116 94 318 131 140 134 60 357 529
2024/20255.284 107 154 91 67 78 576 337 583 786 1.304 573 628
2025/202615.356 2.082 965 1.810 1.704 420 592 3.927 1.115 849 884 536 472
Totale 37.025